Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 5 de 5
Filter
Add more filters










Database
Language
Publication year range
1.
Viruses ; 16(4)2024 04 11.
Article in English | MEDLINE | ID: mdl-38675930

ABSTRACT

Inflammation is a protective host response essential for controlling viral replication and promoting tissue repair [...].


Subject(s)
Inflammation , Virus Diseases , Inflammation/virology , Humans , Virus Diseases/immunology , Virus Diseases/virology , Animals , Viruses/immunology , Viruses/pathogenicity , Virus Replication , Host-Pathogen Interactions/immunology
2.
J Virol ; 98(1): e0110223, 2024 Jan 23.
Article in English | MEDLINE | ID: mdl-38169294

ABSTRACT

Mayaro virus (MAYV) is an emerging arbovirus member of the Togaviridae family and Alphavirus genus. MAYV infection causes an acute febrile illness accompanied by persistent polyarthralgia and myalgia. Understanding the mechanisms involved in arthritis caused by alphaviruses is necessary to develop specific therapies. In this work, we investigated the role of the CCL2/CCR2 axis in the pathogenesis of MAYV-induced disease. For this, wild-type (WT) C57BL/6J and CCR2-/- mice were infected with MAYV subcutaneously and evaluated for disease development. MAYV infection induced an acute inflammatory disease in WT mice. The immune response profile was characterized by an increase in the production of inflammatory mediators, such as IL-6, TNF, and CCL2. Higher levels of CCL2 at the local and systemic levels were followed by the significant recruitment of CCR2+ macrophages and a cellular response orchestrated by these cells. CCR2-/- mice showed an increase in CXCL-1 levels, followed by a replacement of the macrophage inflammatory infiltrate by neutrophils. Additionally, the absence of the CCR2 receptor protected mice from bone loss induced by MAYV. Accordingly, the silencing of CCL2 chemokine expression in vivo and the pharmacological blockade of CCR2 promoted a partial improvement in disease. Cell culture data support the mechanism underlying the bone pathology of MAYV, in which MAYV infection promotes a pro-osteoclastogenic microenvironment mediated by CCL2, IL-6, and TNF, which induces the migration and differentiation of osteoclast precursor cells. Overall, these data contribute to the understanding of the pathophysiology of MAYV infection and the identification future of specific therapeutic targets in MAYV-induced disease.IMPORTANCEThis work demonstrates the role of the CCL2/CCR2 axis in MAYV-induced disease. The infection of wild-type (WT) C57BL/6J and CCR2-/- mice was associated with high levels of CCL2, an important chemoattractant involved in the recruitment of macrophages, the main precursor of osteoclasts. In the absence of the CCR2 receptor, there is a mitigation of macrophage migration to the target organs of infection and protection of these mice against bone loss induced by MAYV infection. Much evidence has shown that host immune response factors contribute significantly to the tissue damage associated with alphavirus infections. Thus, this work highlights molecular and cellular targets involved in the pathogenesis of arthritis triggered by MAYV and identifies novel therapeutic possibilities directed to the host inflammatory response unleashed by MAYV.


Subject(s)
Alphavirus Infections , Arthritis , Chemokine CCL2 , Receptors, CCR2 , Animals , Mice , Alphavirus , Alphavirus Infections/immunology , Arthritis/immunology , Arthritis/virology , Chemokine CCL2/immunology , Interleukin-6/immunology , Mice, Inbred C57BL , Receptors, CCR2/immunology , Mice, Knockout , Male , Bone Diseases/virology
3.
Cells ; 12(8)2023 04 11.
Article in English | MEDLINE | ID: mdl-37190040

ABSTRACT

Dysregulated inflammatory responses are often correlated with disease severity during viral infections. Annexin A1 (AnxA1) is an endogenous pro-resolving protein that timely regulates inflammation by activating signaling pathways that culminate with the termination of response, clearance of pathogen and restoration of tissue homeostasis. Harnessing the pro-resolution actions of AnxA1 holds promise as a therapeutic strategy to control the severity of the clinical presentation of viral infections. In contrast, AnxA1 signaling might also be hijacked by viruses to promote pathogen survival and replication. Therefore, the role of AnxA1 during viral infections is complex and dynamic. In this review, we provide an in-depth view of the role of AnxA1 during viral infections, from pre-clinical to clinical studies. In addition, this review discusses the therapeutic potential for AnxA1 and AnxA1 mimetics in treating viral infections.


Subject(s)
Annexin A1 , Virus Diseases , Humans , Annexin A1/metabolism , Inflammation/metabolism , Signal Transduction
4.
Nutrients ; 11(1)2019 Jan 21.
Article in English | MEDLINE | ID: mdl-30669695

ABSTRACT

This study aimed to evaluate the effect of Lactobacillus reuteri DSM 17938 (DSM) on ethanol-induced gastric injury, and if its possible mechanism of action is related to inhibiting the transient receptor potential vanilloid type 1 (TRPV1). We evaluated the effect of supplementing 108 CFU•g body wt-1•day-1 of DSM on ethanol-induced gastric injury. DSM significantly reduced the ulcer area (1.940 ± 1.121 mm²) with 3 days of pretreatment. The effects of DSM supplementation were reversed by Resiniferatoxin (RTX), TRPV1 agonist (3 nmol/kg p.o.). Substance P (SP) (1 µmol/L per 20 g) plus 50% ethanol resulted in hemorrhagic lesions, and DSM supplementation did not reverse the lesion area induced by administering SP. TRPV1 staining intensity was lower, SP, malondialdehyde (MDA) and nitrite levels were reduced, and restored normal levels of antioxidant parameters (glutathione and superoxide dismutase) in the gastric mucosa in mice treated with DSM. In conclusion, DSM exhibited gastroprotective activity through decreased expression of TRPV1 receptor and decreasing SP levels, with a consequent reduction of oxidative stress.


Subject(s)
Ethanol/adverse effects , Gastric Mucosa/pathology , Limosilactobacillus reuteri/growth & development , Probiotics/therapeutic use , Stomach Ulcer/prevention & control , Substance P/antagonists & inhibitors , TRPV Cation Channels/antagonists & inhibitors , Animals , Antioxidants/metabolism , Diterpenes/pharmacology , Gastric Mucosa/metabolism , Gastric Mucosa/microbiology , Gastritis/chemically induced , Gastritis/metabolism , Gastritis/prevention & control , Glutathione/metabolism , Limosilactobacillus reuteri/classification , Malondialdehyde/metabolism , Mice , Protective Agents/therapeutic use , Species Specificity , Stomach/microbiology , Stomach/pathology , Stomach Ulcer/chemically induced , Stomach Ulcer/metabolism , Stomach Ulcer/pathology , Superoxide Dismutase/metabolism , TRPV Cation Channels/pharmacology
5.
Int J Biol Macromol ; 105(Pt 1): 1105-1116, 2017 Dec.
Article in English | MEDLINE | ID: mdl-28751047

ABSTRACT

Inflammation is a protective reaction of the microcirculation. However, sustained inflammation can lead to undesired effects. Thuja occidentalis Linn has many pharmacological properties but has no anti-inflammatory activity described. Thus, this study aims evaluating the anti-inflammatory activity of the aqueous extract (AE) and the polysaccharide fraction (PLS) of T. occidentalis L. in mice. The results of our evaluations in various experimental models indicated that AE and PLS (3, 10, and 30mg/kg, i.p.) reduced (p˂0.05) paw edema induced by carrageenan, dextran sulfate (DEX), compound 48/80, serotonin (5-HT), bradykinin (BK), histamine (HIST), and prostaglandin E2 (PGE2). Furthermore, it inhibited neutrophils recruitment; decreased MPO activity, tumor necrosis factor-α (TNF-α) and interleukin-6 (IL-6) levels, vascular permeability, nitrite concentration, and MDA concentration; and maintained the GSH levels in the peritoneal exudate. The AE and PLS reduced neutrophil infiltration and cyclooxygenase (COX)-2 and inducible nitric oxide synthase (iNOS) immunostaining in paw tissue. Treatment with the AE and PLS (300mg/kg) did not induce gastric toxicity. In conclusion, these results show that the AE and PLS reduced the inflammatory response by inhibiting vascular and cellular events, inhibiting pro-inflammatory cytokine production, and reducing oxidative stress. Furthermore, they did not induce gastric toxicity at high doses.


Subject(s)
Anti-Inflammatory Agents/pharmacology , Polysaccharides/pharmacology , Thuja/chemistry , Water/chemistry , Animals , Anti-Inflammatory Agents/therapeutic use , Capillary Permeability/drug effects , Edema/drug therapy , Edema/metabolism , Glutathione/metabolism , Interleukin-6/metabolism , Male , Malondialdehyde/metabolism , Mice , Nitric Oxide/biosynthesis , Peritoneal Cavity , Peritonitis/drug therapy , Peroxidase/metabolism , Polysaccharides/therapeutic use , Tumor Necrosis Factor-alpha/metabolism
SELECTION OF CITATIONS
SEARCH DETAIL
...